Measuring the “Unmeasurable”
Assessment of Bone Marrow Response to Therapy Using FDG-PET in Patients with Lymphoma
To access this article, please choose from the options below
Supported in part by a grant from NIH/NCI (3 P30 CA006973-43S2 Abeloff/Wahl for IRAT: Imaging Response Assessment Teams in Cancer Center Supplement).
PII: S1076-6332(10)00253-9
doi:10.1016/j.acra.2010.05.001
© 2010 Published by Elsevier Inc.
